The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients

European Journal of Endocrinology

Volumn 171, Issue 5, 2014, Pages 571-579

  Ragnarsson, Oskar ^a   Mattsson, Anders F ^b   Monson, John P ^c   Nyström, Helena Filipsson ^a   Akerblad, Ann Charlotte ^b   Koltowska Häggström, Maria ^d   Johannsson, Gudmundur ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b PFIZER INC   (United States)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTISONE ACETATE; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; PREDNISOLONE;

ADULT; ARTICLE; CONTROLLED STUDY; FATIGUE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; MEMORY; PATIENT ASSESSMENT; PATIENT SATISFACTION; PHYSICAL ACTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCORING SYSTEM; SOCIAL ISOLATION; TREATMENT RESPONSE; ADDISON DISEASE; ADENOMA; COMPLICATION; MIDDLE AGED; PITUITARY NEOPLASMS;

ADDISON DISEASE; ADENOMA; ADULT; FEMALE; GLUCOCORTICOIDS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOPITUITARISM; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 84910119089     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0397     Document Type: Article

References (39)

1. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. Journal of Clinical Endocrinology and Metabolism 1998 83 382-395. (doi:10.1210/jcem.83.2.4594)
2. Spielhagen C, Schwahn C, Moller K, Friedrich N, Kohlmann T, Moock J, Koltowska-Haggstrom M, Nauck M, Buchfelder M & Wallaschofski H. The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database. Growth Hormone & IGF Research 2011 21 1-10. (doi:10.1016/j.ghir.2010.10.005)
3. Koltowska-Haggstrom M, Mattsson AF, Monson JP, Kind P, Badia X, Casanueva FF, Busschbach J, Koppeschaar HP & Johannsson G. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life? European Journal of Endocrinology 2006 155 109-119. (doi:10.1530/eje.1.02176)
4. Burman P & Deijen JB. Quality of life and cognitive function in patients with pituitary insufficiency. Psychotherapy and Psychosomatics 1998 67 154-167. (doi:10.1159/000012276)
5. van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, van Aken MO, Havekes B, Pereira AM, Pijl H et al. Diseasespecific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clinical Endocrinology 2008 69 775-784. (doi:10.1111/j.1365-2265.2008.03288.x)
6. Santos A, Resmini E, Martinez MA, Marti C, Ybarra J & Webb SM. Quality of life in patients with pituitary tumors. Current Opinion in Endocrinology, Diabetes, and Obesity 2009 16 299-303. (doi:10.1097/MED.0b013e32832cdec9)
7. Bleicken B, Hahner S, Loeffler M, Ventz M, Decker O, Allolio B & Quinkler M. Influence of hydrocortisone dosage scheme on healthrelated quality of life in patients with adrenal insufficiency. Clinical Endocrinology 2010 72 297-304. (doi:10.1111/j.1365-2265.2009.03596.x)
8. Hahner S, Loeffler M, Fassnacht M, Weismann D, Koschker AC, Quinkler M, Decker O, Arlt W & Allolio B. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. Journal of Clinical Endocrinology and Metabolism 2007 92 3912-3922. (doi:10.1210/jc.2007-0685)
9. Lovas K, Loge JH & Husebye ES. Subjective health status in Norwegian patients with Addison's disease. Clinical Endocrinology 2002 56 581-588. (doi:10.1046/j.1365-2265.2002.01466.x)
10. Forss M, Batcheller G, Skrtic S & Johannsson G. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey. BMC Endocrine Disorders 2012 12 8. (doi:10.1186/1472-6823-12-8)
11. Filipsson H, Monson JP, Koltowska-Haggstrom M, Mattsson A & Johannsson G. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. Journal of Clinical Endocrinology and Metabolism 2006 91 3954-3961. (doi:10.1210/jc.2006-0524)
12. Ragnarsson O, Nystrom HF & Johannsson G. Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism. Clinical Endocrinology 2012 76 246-252. (doi:10.1111/j.1365-2265.2011.04174.x)
13. Zelissen PM, Croughs RJ, van Rijk PP & Raymakers JA. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Annals of Internal Medicine 1994 120 207-210. (doi:10.7326/0003-4819-120-3-199402010-00005)
14. Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, HawkinsMM, Bates AS & Stewart PM. ACTH deficiency, higher doses of hydrocortisone replacement,andradiotherapy are independentpredictors of mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2009 94 4216-4223. (doi:10.1210/jc.2009-1097)
15. Benson S, Neumann P, Unger N, Schedlowski M, Mann K, Elsenbruch S & Petersenn S. Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency. European Journal of Endocrinology 2012 167 679-685. (doi:10.1530/EJE-12-0351)
16. Johannsson G, Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, EngstromBE, Olsson T, Ragnarsson O, RybergM et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. Journal of Clinical Endocrinology and Metabolism 2012 97 473-481. (doi:10.1210/jc.2011-1926)
17. Ho KK & 2007 GH Deficiency Consensus Workshop Participants. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology 2007 157 695-700. (doi:10.1530/EJE-07-0631)
18. McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L & Wiren L. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Quality of Life Research 1999 8 373-383. (doi:10.1023/A:1008987922774)
19. Koltowska-Haggstrom M, Hennessy S, Mattsson AF, Monson JP & Kind P. Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency. Hormone Research 2005 64 46-54. (doi:10.1159/000087444)
20. Hernberg-Stahl E, Luger A, Abs R, Bengtsson BA, Feldt-Rasmussen U, Wilton P,Westberg B & Monson JP. Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism 2001 86 5277-5281. (doi:10.1210/jcem.86.11.7997)
21. Danilowicz K, Bruno OD, Manavela M, Gomez RM & Barkan A. Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. Pituitary 2008 11 279-285. (doi:10.1007/s11102-008-0126-2)
22. Groves RW, Toms GC, Houghton BJ & Monson JP. Corticosteroid replacement therapy: twice or thrice daily? Journal of the Royal Society of Medicine 1988 81 514-516.
23. Grossman AB. Clinical Review: The diagnosis and management of central hypoadrenalism. Journal of Clinical Endocrinology and Metabolism 2010 95 4855-4863. (doi:10.1210/jc.2010-0982)
24. Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC & Loriaux DL. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. Journal of Clinical Endocrinology and Metabolism 1991 72 39-45. (doi:10.1210/jcem-72-1-39)
25. Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, Falorni A, Gan EH, Hulting AL, Kasperlik-Zaluska A et al. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. Journal of Internal Medicine 2013 275 104-115. (doi:10.1111/joim.12162)
26. Arlt W. The approach to the adult with newly diagnosed adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism 2009 94 1059-1067. (doi:10.1210/jc.2009-0032)
27. Grossman A, Johannsson G, Quinkler M & Zelissen P. Therapy of endocrine disease: perspectives on the management of adrenal insufficiency: clinical insights from across Europe. European Journal of Endocrinology 2013 169 R165-R175. (doi:10.1530/EJE-13-0450)
28. Lindsay JR, Nansel T, Baid S, Gumowski J & Nieman LK. Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. Journal of Clinical Endocrinology and Metabolism 2006 91 447-453. (doi:10.1210/jc.2005-1058)
29. Iacobone M, Citton M, Viel G, Boetto R, Bonadio I, Mondi I, Tropea S, Nitti D & Favia G. Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome. Surgery 2012 152 991-997. (doi:10.1016/j.surg.2012.08.054)
30. Swinburn CR, Wakefield JM, Newman SP & Jones PW. Evidence of prednisolone inducedmood change ('steroid euphoria') in patients with chronic obstructive airways disease. British Journal of Clinical Pharmacology 1988 26 709-713. (doi:10.1111/j.1365-2125.1988.tb05309.x)
31. Anfinson TJ, Channappa C & Vo HT. Drug dependence involving prednisone: two cases and a review of the literature. Psychopharmacology Bulletin 2008 41 154-163.
32. Bleicken B, Hahner S, Loeffler M, Ventz M, Allolio B & Quinkler M. Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens. European Journal of Endocrinology 2008 159 811-817. (doi:10.1530/EJE-08-0578)
33. Gibney J, Wallace JD, Spinks T, Schnorr L, Ranicar A, Cuneo RC, Lockhart S, Burnand KG, Salomon F, Sonksen PH et al. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. Journal of Clinical Endocrinology and Metabolism 1999 84 2596-2602. (doi:10.1210/jcem.84.8.5916)
34. Svensson J, Finer N, Bouloux P, Bevan J, Jonsson B, Mattsson AF, Lundberg M, Harris PE, Koltowska-HaggstromM & Monson JP. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response. Growth Hormone & IGF Research 2007 17 67-76. (doi:10.1016/j.ghir.2006.11.002)
35. Moore JS, Monson JP, Kaltsas G, Putignano P, Wood PJ, Sheppard MC, Besser GM, Taylor NF & Stewart PM. Modulation of 11b-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. Journal of Clinical Endocrinology and Metabolism 1999 84 4172-4177. (doi:10.1210/jcem.84.11.6108)
36. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M & Stewart PM. 11b-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Reviews 2004 25 831-866. (doi:10.1210/er.2003-0031)
37. Giavoli C, Libe R, Corbetta S, Ferrante E, Lania A, Arosio M, Spada A & Beck-Peccoz P. Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients. Journal of Clinical Endocrinology and Metabolism 2004 89 5397-5401. (doi:10.1210/jc.2004-1114)
38. Swords FM, Carroll PV, Kisalu J, Wood PJ, Taylor NF & Monson JP. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement. Clinical Endocrinology 2003 59 613-620. (doi:10.1046/j.1365-2265.2003.01894.x)
39. Oksnes M, Bensing S, Hulting AL, Kampe O, Hackemann A, Meyer G, Badenhoop K, Betterle C, Parolo A, Giordano R et al . Quality of life in European patients with Addison's disease: validity of the disease specific questionnaire AddiQoL. Journal of Clinical Endocrinology and Metabolism 2012 97 568-576. (doi:10.1210/jc.2011-1901)